Managing DirectorArgent Global Services
Disclosure information not submitted.
Exploring EGFR exon 20 insertions in NSCLC and the FDA-approved Oncomine Dx Express Test for CDx and tumor profiling
Wednesday, November 12, 20259:00 AM - 9:50 AM EST